We are live on ! Find out more
MC

Mayo Clinic Portfolio holdings

AUM $2.9M
1-Year Est. Return 14.49%
This Fund
S&P 500
This Quarter Est. Return
+32.06%
1 Year Est. Return
+14.49%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$83.1M
AUM Growth
+$8.91M
Cap. Flow
+$1.24M
Cap. Flow %
1.49%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
SRNE
Sorrento Therapeutics, Inc.
SRNE
+$5.28M

Sector Composition

Rank Sector Weight
1 Healthcare 46.13%
2 Energy 45.97%
3 Miscellaneous 7.43%
4 Financials 0.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSM icon
1
Black Stone Minerals
BSM
$3.14B
$38.2M 45.97%
5,719,924
ZNTL icon
2
Zentalis Pharmaceuticals
ZNTL
$360M
$18.8M 22.65%
362,459
-80,255
-18% -$3.62M
UBX
3
DELISTED
Unity Biotechnology
UBX
$8.24M 9.91%
157,198
SPY icon
4
State Street SPDR S&P 500 ETF Trust
SPY
$825B
$6.17M 7.43%
16,511
EVLO
5
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$5.86M 7.05%
24,248
SRNE
6
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$4.49M 5.41%
+657,877
New +$5.28M
CLPT icon
7
ClearPoint Neuro
CLPT
$474M
$749K 0.9%
47,148
STEX
8
Streamex Corp
STEX
$89.9M
$393K 0.47%
10,089
EXAS
9
DELISTED
Exact Sciences
EXAS
$173K 0.21%
1,304
-1,985
-60% -$240K
VYNT
10
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
-89
Closed -$184K

Similar funds

Mayo Clinic's Q4 2020 Portfolio in Review

As of Q4 2020, Mayo Clinic held 10 positions worth $83.1M, up 12% from $74.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Mayo Clinic's Q4 2020 filing shows 1 new, 2 reduced and 1 closed positions. Its largest new stake was Sorrento Therapeutics, Inc.: 657,877 shares worth $4.49M. The largest sale was Zentalis Pharmaceuticals, an estimated $3.62M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 39% a quarter earlier, followed by Energy and Miscellaneous.

  • Mayo Clinic's largest Q4 2020 buy was Sorrento Therapeutics, Inc.: 657,877 shares worth $4.49M.
  • Mayo Clinic's biggest Q4 2020 reduction was Zentalis Pharmaceuticals, cutting an estimated $3.62M.
  • Mayo Clinic fully exited Vyant Bio, Inc. Common Stock in Q4 2020, selling an estimated $184K.
  • Mayo Clinic's ten largest holdings make up 100% of its $83.1M portfolio in Q4 2020.
  • Mayo Clinic opened 1 new position and closed 1 in Q4 2020.
  • Mayo Clinic's portfolio value rose 12% quarter-over-quarter to $83.1M.

Based on Mayo Clinic's 13F filing for Q4 2020, filed 11 Feb 2021.